Kronos Bio KRON
$ 0.96
3.21%
Quarterly report 2024-Q3
added 11-13-2024
Kronos Bio Balance Sheet 2011-2024 | KRON
Annual Balance Sheet Kronos Bio
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-36.1 M | -44.9 M | -165 M | -216 M | -32 M | -9.46 M | - | - | - | - | - | - | - |
Long Term Debt |
25.4 M | 28.7 M | 31.7 M | 31.1 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
2.89 M | 2.35 M | 2.11 M | 937 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 33.6 M | 123 M | 18.6 M | - | - | - | - | - | - | - |
Total Current Liabilities |
24.7 M | 21.5 M | 13.6 M | 12.9 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
54.2 M | 50.4 M | 46.4 M | 46.4 M | 126 M | 19.9 M | - | - | - | - | - | - | - |
Deferred Revenue |
9.58 M | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-509 M | -396 M | -263 M | - | -23.5 M | -7.34 M | - | - | - | - | - | - | - |
Total Assets |
213 M | 295 M | 391 M | 512 M | 103 M | 12.6 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
64.3 M | 76 M | 198 M | 248 M | 32.6 M | 10.2 M | - | - | - | - | - | - | - |
Book Value |
159 M | 244 M | 345 M | 466 M | -23.2 M | -7.3 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
159 M | 244 M | 345 M | 466 M | -23.2 M | -7.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Kronos Bio
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
22.5 M | 23.5 M | 24.5 M | 25.4 M | 26.3 M | 27.1 M | 27.9 M | 28.7 M | 29.5 M | - | 31 M | 31.7 M | 32.3 M | 32.8 M | 29.4 M | - | - | 31.1 M | 31.1 M | 5 K | 5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
38.9 M | 41.1 M | 46 M | 54.2 M | 59.4 M | 57.3 M | 63.4 M | 50.4 M | 50 M | - | 48.8 M | 46.4 M | 48.5 M | 47.6 M | 42.7 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 2.98 M | 2.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
5.16 M | 7.53 M | 8.67 M | 9.58 M | 8.58 M | 8.82 M | 8.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-569 M | -555 M | -539 M | -509 M | -484 M | -452 M | -422 M | -396 M | -364 M | - | -299 M | -263 M | -201 M | -167 M | -138 M | -112 M | -112 M | -112 M | -112 M | -23.5 M | -23.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
150 M | 164 M | 183 M | 213 M | 238 M | 261 M | 289 M | 295 M | 318 M | - | 366 M | 391 M | 448 M | 472 M | 488 M | 512 M | 512 M | 512 M | 512 M | 103 M | 103 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
75 M | 70.2 M | 46.2 M | 64.3 M | 57.6 M | 44.4 M | 61.6 M | 76 M | 67.5 M | 86.1 M | 149 M | 198 M | 217 M | 186 M | 141 M | 248 M | 248 M | 248 M | 248 M | 32.6 M | 32.6 M | - | - | 10.2 M | - | - | - | 1.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
111 M | 123 M | 137 M | 159 M | 179 M | 203 M | 226 M | 244 M | 268 M | - | 317 M | 345 M | 399 M | 424 M | 445 M | 466 M | 466 M | 466 M | 466 M | 99.7 M | 99.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
111 M | 123 M | 137 M | 159 M | 179 M | 203 M | 226 M | 244 M | 268 M | 292 M | 317 M | 345 M | 399 M | 424 M | 445 M | 466 M | 466 M | 466 M | 466 M | -23.2 M | -23.2 M | -13.9 M | -10.4 M | -7.3 M | - | - | - | -610 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency